CellProthera

    OverviewSuggest Edit

    CellProthera is a medical biotech company founded in 2008 in Mulhouse (France). Its activity is currently focused on the development of a revolutionary therapeutic approach allowing the regeneration of myocardial tissue following acute myocardial infarct by injection of a cell graft containing autologous adult stem cells (ASC) sampled directly from the patient. CellProthera is the first company having conducted successful proof of principle study with autologous CD34+ stem cells to repair myocardial tissue after acute myocardial infarct (AMI). The clinical outcome indicated an excellent safety profile associated with outstanding clinical benefits. The innovative approach developed by CellProthera is viewed by experts as one of the most effective to treat AMI and prevent secondary congestive heart failure (CHF). This “rupture” therapy has been assessed in a preliminary Proof of Concept clinical trial. This represents a unique alternative to cardiac transplant and can be a complement and/or a substitute for existing therapies like coronary bypass surgery and stenting.
    TypePrivate
    Founded2008
    HQMulhouse, FR
    Websitecellprothera.com

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Sep 2019)24

    Key People/Management at CellProthera

    Matthieu de

    Matthieu de

    CEO
    Jean-Philippe Veillard

    Jean-Philippe Veillard

    CFO
    Show more

    CellProthera Office Locations

    CellProthera has an office in Mulhouse
    Mulhouse, FR (HQ)
    12 Rue du Parc
    Show all (1)

    CellProthera Financials and Metrics

    Summary Metrics

    Founding Date

    2008

    CellProthera Online and Social Media Presence

    Embed Graph

    CellProthera Blogs

    [2019-01] Financial Manager (M/W)

    Financial Manager (M/W) CellProthera is a biotech company based in France (Alsace) developing innovative cell therapy products (ATMP) based on a proprietary bioprocessing technology. A multi-center Phase I/IIb clinical trial is currently on-going in Europe for the treatment of Acute Myocardial Infar…

    [2018-12] Quality Manager

    Quality Manager (M/W) CellProthera is a biotech company based in France (Alsace) developing innovative cell therapy products (ATMP) based on a proprietary bioprocessing technology. A multi-center Phase I/IIb clinical trial is currently on-going in Europe for the treatment of Acute Myocardial Infarct…

    [2018-08] Clinical Project Manager

    Clinical Project Manager (M/W) CellProthera is a biotech company based in Alsace. Being a Pharmaceutical entity, our Firm develops an advanced therapeutic medicinal product on a stem cell therapy graft approach to treat patients suffering from severe acute myocardial infarction. A Phase I/IIb clinic…

    CellProthera Frequently Asked Questions

    • When was CellProthera founded?

      CellProthera was founded in 2008.

    • Who are CellProthera key executives?

      CellProthera's key executives are Matthieu de and Jean-Philippe Veillard.

    • How many employees does CellProthera have?

      CellProthera has 24 employees.

    • Who are CellProthera competitors?

      Competitors of CellProthera include LifebankUSA, Lyra Therapeutics and Kyn Therapeutics.

    • Where is CellProthera headquarters?

      CellProthera headquarters is located at 12 Rue du Parc, Mulhouse.

    • Where are CellProthera offices?

      CellProthera has an office in Mulhouse.

    • How many offices does CellProthera have?

      CellProthera has 1 office.